Image of hands wearing latex gloves, filling a syringe with vaccine

Skip to Content

North Bay Parry Sound District Health Unit Logo North Bay Parry Sound District Health Unit Logo Print

Contact Us
  • Public Health
    Services
    • Breastfeeding Clinic
    • Community Events and Farmers Markets
    • Dental Clinic
    • Family Health Information Line
    • Food Safety Certification Training
    • Healthy Babies, Healthy Children
    • Infection Prevention and Control Investigations
    • Inspection Results and Enforcement
    • Needle Syringe Program
    • Parenting Workshops
    • Prenatal Classes
    • Private Drinking Water Testing
    • The Sexual Health Clinic
    • Vaccination Clinics
    • Vaccination Records
    • Vision Screening
  • Health
    Topics
    • 2SLGBTQ+
    • Air Quality
    • Alcohol
    • Animal Bites
    • Beach, Lake and Pool Water
    • Breastfeeding
    • Cancer Prevention and Screening
    • Climate Change
    • Dental Health
    • Diseases
    • Drinking Water
    • Emergencies and Being Prepared
    • Farm Fresh Eggs
    • Flu/Influenza
    • Food Poisoning
    • Food Safety
    • Gambling
    • Healthy Aging
    • Healthy Eating
    • Heat and Humidity
    • Home Health and Safety
    • Housing and Homelessness
    • Injury Prevention
    • Intimate Partner Violence
    • Mental Health
    • Naloxone
    • Parenting
    • Perfluoroalkylated Substances (PFAS)
    • Physical Activity
    • Pregnancy
    • Racism
    • Reducing Weight Bias
    • Sexual Health
    • Sharps
    • Smoking, Vaping and Tobacco
    • Substance Use
    • Suicide Prevention
    • Vaccinations
    • Youth Engagement – IMPACT
  • Health Professionals
    and Partners
    • Camp Providers
    • Child Cares
    • COVID-19 Healthcare Providers, Hospitals and Long-Term Care
    • Designated Officers
    • Emergency Management
    • Group Home and Shelter Administrators
    • Health Care Professionals
    • Health Care Providers COVID-19 Vaccine Information
    • Long-Term Care and Retirement Homes
    • Municipal Resources
    • Nutrition Resources
    • Ontario Naloxone Program (ONP) Distributing Agencies and First Responders
    • Personal Service Settings
    • Report an Overdose
    • Schools
    • Teaching Kitchen
  • Community Data
    and Reports
    • Chronic Diseases
    • Environmental Health
    • Health Behaviours
    • Indirect Impacts of COVID-19
    • Infectious Diseases
    • Injuries
    • Mortality
    • Nipissing Parry Sound Public Health Atlas
    • Oral Health
    • Population Demographics
    • Reproductive and Child Health
    • Substance Use Reporting
    • Well-being and Mental Health
  • About Us
    • About Us
    • Accessibility
    • Board of Health
    • Careers and Placements
    • Contact Us
    • News and Events
    • Personal Health Privacy Policy
    • Programs and Services
    • RFPs and Tenders
Search Button

Back To Top

Health Care Providers COVID-19 Vaccine Information

HomeHealth Professionals and PartnersHealth Care Providers COVID-19 Vaccine Informatio...
  • Open new window to share this page via Facebook Facebook
  • Open new window to share this page via Twitter Twitter
  • Open new window to share this page via LinkedIn LinkedIn
  • Email this page Email

COVID-19 Vaccine Resources

  • COVID-19 Vaccine Guidance (Ministry of Health and Long-Term Care)
  • Guidance on the use of COVID-19 vaccines in the fall of 2023 (National Advisory Committee on Immunization)

Child and Youth Vaccination

Individuals aged five years and older should consider delaying their COVID-19 booster until Fall, 2023, to maximize protection against COVID-19 outcomes when peak circulation of the virus is expected.

For guidance, see Tables 1 and 2 in the Ontario Ministry of Health's COVID-19 Vaccine Guidance document. 

Additional:

  • CARD System for Coping with Vaccinations (SickKids)
  • Immunization Pain Management (clinician focus) (Immunize Canada)
  • Vaccine Hesitancy and First Nations, Inuit and Métis Populations – Potential Implications During COVID-19 (National Collaborating Centre for Infectious Diseases)
  • Vaccine Hesitancy Guide – Developed by Clinicians Across Canada (School of Public Policy – University of Calgary)

mRNA Vaccines

  • Public Health Ontario: COVID-19: What You Need to Know about mRNA Vaccines
  • Public Health Ontario: COVID-19 Vaccines: mRNA Vaccines

Protein Subunit Vaccines

The Novavax NuvaxovidTM vaccine is an adjuvanted vaccine containing recombinant COVID-19 spike protein fragments. For more information on the vaccine, please see the WHO Vaccine Explainer on protein subunit vaccines.

We recommend eligible individuals receive an mRNA vaccine, such as Moderna or Pfizer. However, we will offer the Novavax vaccine to those who meet the following criteria:

  • Are 12 years of age or older;

  • Live, work, or attend school in the Nipissing or Parry Sound district;

  • Do NOT have a confirmed allergy to any of the vaccine components or its container (the vial stopper is bromobutyl rubber, which is latex free). Please see Health Canada for a full list of vaccine ingredients;

  • Are not able to receive an mRNA vaccine due to contraindications, or would prefer not to receive an mRNA vaccine.

The safety and efficacy of Novavax have not been established in individuals who are immunocompromised due to disease or treatment. Informed consent for use of the vaccine in this population should include discussion that there is currently limited evidence on the use of Novavax in this population, while there is evidence on the safety profile and effectiveness of mRNA COVID-19 vaccines in these populations based on real world use with large numbers of individuals (CIG, 2022). 

For more information or to arrange an appointment for Novavax, contact us at 1-800-563-2808.

Viral Vector Vaccines

Astra Zeneca, Medicago and Janssen COVID-19 vaccines are no longer being used in Ontario.

Vaccine Recommendations for Specific Health Conditions

Pregnancy and Breastfeeding

Since the beginning of the COVID-19 pandemic, evidence has evolved to indicate that pregnancy is a risk factor for severe outcomes of COVID-19, so it is especially for these individuals to stay up to date with COVID-19 vaccination.

  • A COVID-19 vaccine may be offered at any stage of the pregnancy (i.e., in any trimester).

  • COVID-19 vaccines may be co-administered with other vaccines recommended during pregnancy or while breastfeeding.

  • NACI strongly recommends that individuals who are pregnant or breastfeeding who have not yet begun or completed the primary series should be offered the recommended doses to complete the primary series.

  • Pregnant and breastfeeding individuals are also encouraged to be up to date with booster doses.

Immunocompromised Individuals

For moderately and severely immunocompromised individuals, a primary COVID-19 vaccines series comprises three doses.

Individuals 6 months and older who are moderately to severely immunocompromised may benefit from a primary series with bivalent Moderna (25 mcg in 6 months-11 years and 50mcg in those 12 years and older) compared to bivalent Pfizer (10 mcg in 5-11 years and 30 mcg in those 12 years and older).

For individuals 12-29 years of age, the bivalent Pfizer (30mcg) vaccine is preferred due to the lower risk of myocarditis and/or pericarditis, however, for some moderately to severely immunocompromised individuals, administration of the bivalent Moderna (50 mcg) may be considered based on the individual clinician judgement and informed consent.

An extended primary series is recommended for the following populations:

  • Individuals receiving dialysis (hemodialysis or peritoneal dialysis)

  • Recipients of solid-organ transplant and taking immunosuppressive therapy

  • Individuals receiving active treatment (e.g., chemotherapy, targeted therapies, immunotherapy) for solid tumour or hematologic malignancies.

  • Recipients of chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)

  • Individuals with moderate to severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome)

  • HIV and AIDS-defining illness in last 12 months before starting vaccine series, or severe immune compromise with CD4 count <200 cells/uL or CD4 percentage <15%, or without HIV viral suppression.

  • Individuals receiving active treatment with the following categories of immunosuppressive therapies:  anti-B cell therapies (monoclonal antibodies targeting CD19, CD20 and CD22), high-dose systemic corticosteroids.

Myocarditis/Pericarditis

There have been Canadian and international reports of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines. The majority of cases have responded well to conservative therapy and tend to recover quickly.

  • Symptoms have typically been reported to start within one week after vaccination.

  • Cases of myocarditis/pericarditis following COVID-19 mRNA vaccination occur more commonly in adolescents and young adults (12-29 years), more often after the second dose and more often in males than females.

NACI continues to strongly recommend that a complete series with an mRNA COVID-19 vaccine be offered to all eligible individuals in Canada including those 5 years and older.

The benefits of vaccination with COVID-19 vaccines continue to outweigh the risks of COVID-19 illness and related, possibly severe outcomes for all age groups.

Anyone receiving an authorized mRNA COVID-19 vaccine should be informed of the risk of myocarditis and pericarditis, and advised to seek medical attention if they develop symptoms including chest pain, shortness of breath, palpitations, or feeling of rapid or abnormal heart rhythm.

In most circumstances, and as a precautionary measure until more information is available, individuals with a diagnosed episode of myocarditis within 6 weeks of receipt of a previous dose of an mRNA COVID-19 vaccine should defer further doses of the vaccine. This includes any person who had an abnormal cardiac investigation including electrocardiogram, elevated troponins, echocardiogram or cardiac MRI after a dose of an mRNA vaccine.

This is a precaution based on recommendations issued by NACI, CIG, PHO, and MOH.

In situations where there is uncertainty regarding myocarditis diagnosis, discussion should occur with an appropriate health care provider on potential options for (re) immunization with the same or alternative COVID-19 vaccine, including a risk-benefit analysis for the individual.

Those with a history compatible with pericarditis and who either had no cardiac work or had normal cardiac investigations, can receive the next dose once they are symptom free and at least 90 days has passed since vaccination.

Some people with confirmed myocarditis with or without pericarditis may choose to receive another dose of vaccine after discussing the risks and benefits with their health care provider.

  • Individuals can be offered the next dose once they are symptom free and at least 90 days has passed since vaccination.
  • If another dose of vaccine is offered, they should be offered the bivalent Pfizer-BioNTech (30 mcg) vaccine due to the lower reported rate of myocarditis and/or pericarditis when offered as part of e primary series.
  • Informed consent should include discussion about the unknown risk of recurrence of myocarditis and/or pericarditis following receipt of additional doses, as well as the need to seek immediate medical assessment and care should symptoms develop.

Multi-Inflammatory Syndrome in Children or in Adults (MIS-C/Afollowing vaccination with an mRNA COVID-19 vaccine

Children and adolescents with SARS-CoV-2 infection are at risk of MIS-C in children, a rare but serious syndrome that can occur several weeks following SARS-CoV-2 infection. Very rare cases of MIS-C/A have been reported following vaccination with COVID-19 mRNA vaccines in Canada and internationally among individuals aged 12 years and older.

For children or adults with a previous history of multisystem inflammatory syndrome (MIS-C/A), unrelated to any previous COVID-19 vaccination, vaccination should be postponed until clinical recovery has been achieved or until it has been greater than 90 days since diagnosis, whichever is longer.

Bell’s palsy following vaccination with an mRNA COVID-19 vaccine

Very rare cases of Bell’s palsy have been reported following vaccination with COVID-19 mRNA vaccines in Canada and internationally among individuals 12 years and older. Bell’s palsy is an episode of facial muscle weakness or paralysis. The condition is typically temporary. Symptoms appear suddenly and generally start to improve after a few weeks.

Symptoms of Bell’s palsy may include: 

  • Uncoordinated movement of the muscles that control facial expressions, such as smiling, squinting, blinking or closing the eyelid

  • Loss of feeling in the face

  • Headache

  • Tearing from the eye

  • Drooling

  • Lost sense of taste on the front two-thirds of the tongue

  • Hypersensitivity to sound in the one ear

  • Inability to close an eye on one side of the face

Health care professionals should submit an adverse event following immunization (AEFI) when Bell’s Palsy has occurred following immunization.

History of Allergies

  • People who experienced a severe immediate allergic reaction after a dose of an mRNA COVID-19 vaccine can safely receive future doses of the same or another mRNA COVID-19 vaccine after consulting with an allergist/immunologist or another appropriate physician.
  • Individuals with a suspected history of adverse reactions to tromethamine, including suspected history of systemic allergic reactions to radiocontrast media and ketorolac, may receive vaccines containing tromethamine.
  • Individuals with known allergies to components of the vaccines may speak with an appropriate physician or nurse practitioner for evaluation and creation of a vaccination care plan.

Symptoms either current or displayed recently, of chest pain or shortness of breath

  • Vaccine should not be offered to persons displaying current or recent history of chest pain or shortness of breath.
  • Those with symptoms should contact their health care provider or should be directed to the emergency department or instructed to call 911.

Addressing Vaccine Hesitancy

  • National Institutes of Health: Health Communicator’s Tip Sheet: The Do's and Don'ts for COVID-19 Vaccine Conversations
  • Building Confidence in Vaccines (PHO)
  • The SickKids Vaccine Confidence Support Resource List
  • Conversations in Vaccine Confidence, a Guide and Toolkit (OCAD University, VaxFacts Clinic, Scarborough Health Network, Fall 2021)
  • VaxFacts Poster
  • SickKids COVID-19 Vaccine Consult Service Poster

Booster Dose Recommendations and Staying-Up-to-Date

Booster Doses

Individuals 5 years and older should consider delaying receipt of a COVID-19 vaccine booster until Fall 2023.

Receiving a booster dose in the Fall, as respiratory season commences, will maximize protection against COVID-19 when peak circulation of the virus is expected.

The decision to receive a booster dose prior to Fall 2023 may be appropriate for certain individuals based on their unique health status and personal situation.

Staying Up-to-Date

For those 6 months – 4 years, up-to-date means having a completed primary series. Booster doses are not currently recommended for this age group.

For those 5 years and older, up-to-date means completion of the primary series and receipt of the currently recommended booster dose.

COVAXon Basics for Health Care Providers

Getting Involved in COVID-19 Vaccine Administration

How do I order COVID-19 vaccine for my practice/clinic?

If you're interested in ordering COVID-19 vaccine for your practice and/or clinic, please contact us at covidinventory@healthunit.ca.

In order to provide COVID-19 vaccine in the province of Ontario, you must have access to the Covax documentation system.

We can request access to Covax for you and/or your staff and can provide a brief virtual orientation session to Covax and the COVID-19 vaccine ordering process. Please contact the Health Unit at covax@healthunit.ca for more information.

If you are a pharmacy and would like to start offering the COVID-19 vaccine, you must contact the Ontario Pharmacists Association for further direction on how to get involved in the COVID-19 vaccine roll-out.

COVID-19 vaccine allocation is provided to pharmacies directly from the Ministry of Health in partnership with the Ontario Pharmacists Association.

Pharmacies use Covax for documentation and can reach out to us for further information and/or training related to Covax.

How to Request Access to Covax

Covax is the provincial documentation system for the COVID-19 vaccine. In order to provide vaccination in Ontario, you must have a profile in the Covax.

We can request access to Covax for you and/or your staff and can provide orientation to Covax and the COVID-19 vaccine ordering process. Please contact us at covax@healthunit.ca for further information.

How to Set a Password

You will receive an email from Salesforce, which contains a link. When you click on this link it will provide you with prompts to successfully set up your password. The link found in the email is only active for a 24-hour period. You can contact us or call or Covax Support at 1-888-333-0640 to request a password reset if the link is no longer active.

Covax is web-browser sensitive and the following web-browsers are recommended:

  • Safari
  • Edge
  • Mozilla Firefox
  • Chrome

2-Step Authentication

Each time you log on to Covax, you will need to validate your identity using Two-factor Authentication (2FA), (often referred to as 2-step authentication) which adds a second layer of security.

You will need to download the free Salesforce Authenticator App on your personal cell phone at the same time as you set up your Covax account.

You will be prompted to use the 2-factor authentication each time you sign into Covax, and will need your cell phone each time you log on.

Contact us at covax@healthunit.ca if you require further assistance.

How to Log On and Off

Open a new tab in your web browser and go to covaxon.my.salesforce.com.

Log on with your username and password. You will then be prompted to the 2-factor authentication using your personal cell phone.

You can contact the provincial COVAXon support services desk at 1-888-333-0640 if you are having any difficulty logging on.

Log off can be found in the top right-hand corner of the Covax screen when you click on the little creature in the circle.

Covax is web-browser sensitive and the following web-browsers are recommended:

  • Safari
  • Edge
  • Mozilla Firefox
  • Chrome

How to Request a Password Reset

Contact us at covax@healthunit.ca, or email COVax Support at COVaxonSupport@ontario.ca to request a password reset.

Why my account isn't working (30 day de-activation) and how to resolve

Covax accounts are disabled after a 30-day period with no activity.

We are able to reactivate your Covax account. Please contact us at covax@healthunit.ca to request a reactivation of your account.

How to Search for Clients

Using the tabs on the top of the Covax page, click on the ‘Client Search’ tab. This will open a window requesting the client's Ontario Health Card Number. Enter the Health Card number.

  • If the client has been entered into Covax, the search will generate a result.

  • If the client has not been entered into Covax, you will be prompted to search for the client using different parameters such as First Name, Last Name, Date of Birth, etc. If no client is found with these additional identifiers, it will prompt you to search the Ontario Health Card Provincial registry using the health card number.
  • If client has an Ontario Health Card number they will be found in the provincial registry, even if the client has an expired health card or an older red and white health card.
  • If a client has an Ontario Health Card and are not found in the system, please contact the COVaxon Support Desk Services for support. Do not create a new client record for client unless directed by the support desk.

In Ontario, we provide free vaccine to all people, regardless of whether they are a permanent resident of Ontario. In the instance of vaccinating a client who does not have an Ontario Health Card, they will not be in the provincial registry and you may have to create the client.

If this is the client's second dose of vaccine in Ontario, they will be in Covax. If this is the first dose of vaccine in Ontario, they may not be in Covax.

Select the ‘HCN unavailable’ box and use other search parameters to attempt to search for client in Covax. If not found, create a new client record for client.

New Immunization

This function is found in the upper right-hand corner of the client file. Once a client is connected to the correct vaccination event, you are able to click on the New Immunization function to document that the client has received the vaccine and send the vaccine receipt to client via email.

Contact us at covax@healthunit.ca if you are having any difficulty using these functions in Covax, finding the correct vaccination event, or finding active inventory in the vaccination event.

Vaccination Events

A vaccination event is a clinic and/or location that a client is receiving a vaccine. The vaccination event is created by the Health Unit when a vaccination order is made and will be reused for all future vaccine orders from your organization.

When the vaccine is physically allocated to different locations the vaccination event is virtually allocated the vaccine. All clients who are vaccinated at a specific location need to be connected to the vaccination event in order to have their dose documented.

Contact the Health Unit at covax@healthunit.ca if you are having difficulty finding the correct vaccination event, or finding active inventory in the vaccination event.

Note: Vaccination events can represent a mobile clinic, and are not necessarily physical locations.

Inventory Reconciliation

Complete the inventory form after each day that COVID-19 vaccine doses have been administered.

Offices can monitor their own inventory at the vaccination event level. At the end of each day that your office/clinic/practice administers vaccine, ensure that your physical inventory matches the Covax inventory.

Covax automatically adjusts inventory for all doses administered; however, all wastage, extra doses, or clients who do not provide consent will need to be adjusted manually. For more information on how to make these adjustments to the virtual inventory, the Health Unit can provide a 15-minute virtual live demonstration on how to make the adjustments. 

Contact us at covax@healthunit.ca if you are having difficulty reconciling your inventory. 

Emerging Research

PHO provides, and regularly updates, synopses of key research articles related to COVID-19:

Emerging Topics: Synopsis of COVID-19 Key Research Articles

COVID-19 Serology

  • Coronavirus Disease 2019 (COVID-19) – Serology

  • COVID-19 Antibody (Serology) Testing – Information for Patients

Medical Exemptions to COVID-19 Vaccines

Medical Exemptions to COVID-19 Vaccination (Ministry of Health)

Medical Exemptions to COVID-19 Vaccination and New Clinical Trial Exemption Process

Physician and Nurse Practitioner offices needing to request a Medical Exemption Form please email vpd@healthunit.ca

See also: COVID-19 Information for Healthcare Providers, Hospitals and Long-Term Care

Health Professionals and Partners
    • Camp Providers
      Toggle Section Camp Providers Menu
      • Cleaning Recommendations During an Outbreak
    • Child Cares
    • COVID-19 Healthcare Providers, Hospitals and Long-Term Care
    • Designated Officers
    • Emergency Management
      Toggle Section Emergency Management Menu
      • Municipalities
      • Personal Preparedness
        Toggle Section Personal Preparedness Menu
        • Emergency Kits
        • Resources
    • Group Home and Shelter Administrators
    • Health Care Professionals
      Toggle Section Health Care Professionals Menu
      • Breastfeeding resources
      • Communicable Disease Control
        Toggle Section Communicable Disease Control Menu
        • C. Difficile
        • MRSA
        • Tuberculin Skin Testing Guide
      • Harm Reduction
      • Local Influenza Activity
    • Health Care Providers COVID-19 Vaccine Information
    • Long-Term Care and Retirement Homes
      Toggle Section Long-Term Care and Retirement Homes Menu
      • Communicable Disease Outbreaks in Long-Term Care Settings
    • Municipal Resources
    • Nutrition Resources
      Toggle Section Nutrition Resources Menu
      • Adventures in Cooking
    • Ontario Naloxone Program (ONP) Distributing Agencies and First Responders
    • Personal Service Settings
    • Report an Overdose
    • Schools
      Toggle Section Schools Menu
      • Ecoles
      • HOT TOPICS
      • Sujets d'actualité
      • School and Classroom Supports
        Toggle Section School and Classroom Supports Menu
        • Body Image at School Classroom
        • Hand Hygiene in Schools Classroom
        • Healthy Eating - Classroom and Educators Supports
        • Human Development and Sexual Health - Classroom and Educator Supports
        • Immunizations - Classroom and Educator Supports
        • Mental Health For Educators
        • Oral Health in Schools for Educators
        • Personal Safety and Injury Prevention in Schools Classroom Supports
        • Physical Activity at School Classroom & Educators
        • Planetary Health Education for Educators
        • Tobacco, Vape, Drugs and Alcohol Prevention for Educators
      • Soutiens pour la classe et les éducatuers
        Toggle Section Soutiens pour la classe et les éducatuers Menu
        • Human Development and Sexual Health - Classroom and Educator Supports
        • Hygiène des mains - soutiens pour des éducateurs
        • Image corporelle - soutiens pour des éducateurs
        • L’activité physique à l’école - soutiens pour des éducateurs
        • L’alimentation saine à l’école - soutiens pour des éducateurs
        • La santé planétaire - soutiens pour des éducateurs
        • Prévention des blessures à l’école - soutiens pour des éducateurs
        • Santé mentale - soutiens pour las classe et les éducateurs
        • Vaccinations - soutiens pour la classe et les éducateurs
      • School and Administrator Page
        Toggle Section School and Administrator Page Menu
        • Body Image for schools and administration
        • Hand Hygiene - Schools and Administration
        • Healthy Eating - School and Administration
        • Human Development and Sexual Health - Schools and Administration
        • Immunizations - For School and Administration
        • Mental Health - Schools and Administration
        • Personal Safety and Injury Prevention - School and Administration Supports
        • Planetary Health Education - Schools and Administration
        • Tobacco, Vape, Drugs and Alcohol Prevention - Schools and Administration
      • Soutien scolaire et administratif
        Toggle Section Soutien scolaire et administratif Menu
        • Developpement humain et sante sexuelle - soutien scolaire et administratif
        • L’activité physique à l’école soutiens administratif
        • L’alimentation saine à l’école - soutiens administratif
        • La santé planétaire - soutiens administatif
        • Santé mentale - soutiens scolaire et administratif
        • Prévention des blessures à l’école - soutien administratif
      • Lending Library and Apps
        Toggle Section Lending Library and Apps Menu
        • Vaping: What’s the Hype?
          Toggle Section Vaping: What’s the Hype? Menu
          • Addiction Activities for Teachers and Students
          • Flavours
          • From Vaping to Smoking?
          • Health Effects
          • Marketing
          • Nicotine and the Brain
          • The Law - Supplying
          • The Tobacco Industry
          • The Law - Property
      • Bibliothéque de prêt
        Toggle Section Bibliothéque de prêt Menu
        • Trousse d’outils sur le vapotage
          Toggle Section Trousse d’outils sur le vapotage Menu
          • Dépendance
          • Du vapotage à la cigarette ?
          • Effets sur la santé
          • La loi – Endroits où il est interdit de fumer et de vapoter
          • La loi – Fournir des produits de vapotage
          • La nicotine et le cerveau
          • L’industrie du tabac
          • Marketing
          • Produits aromatisés
    • Teaching Kitchen

Contact Us

Subscribe to this page

North Bay Parry Sound District Health Unit Footer Logo

  • Website

    • About Us
    • Employment Opportunities
    • News
  • Links

    • Accessibility
    • Privacy
    • Sitemap
    • Staff Intranet
  • Resources

    Increase Contrast

Your lifetime partner in healthy living!

Copyright 2022 North Bay Parry Sound District Health Unit

By GHD Digital

Browser Compatibility Notification

It appears you are trying to access this site using an outdated browser. As a result, parts of the site may not function properly for you. We recommend updating your browser to its most recent version at your earliest convenience.